We work with both academic and corporate investigators worldwide to provide high-quality human tissue and cells to advance biomedical research.
NDRI tailors human tissue acquisition to meet the specific needs of approved research projects. NDRI can provide tissue types from:
Preservation methods include frozen, fixed, or fresh in media with antibiotics suitable for various analytical techniques.
NDRI works directly with Organ Procurement Organizations (OPOs), tissue banks, eye banks, hospitals, pathologists, medical examiners, and recovery specialists across the United States to coordinate the collection of tissues 24 hours a day, 7 days a week.
NDRI also offers the following services to assist researchers through all phases of project initiation, launch and execution:
Founded in 1980, the National Disease Research Interchange (NDRI), is a non-profit 501(c)(3) that ships thousands of biospecimens annually from our nationwide procurement network to researchers worldwide. NDRI is the nation’s leading source of human tissues, cells and organs for scientific research. The National Institutes of Health (NIH) has provided funding to NDRI since 1987.
NDRI is accredited by the College of American Pathologists (CAP) as a biorepository and a sponsor facility. This biorepository accreditation meets the standards for human biospecimen collection, storage, informatics, and distribution defined by the CAP Biorepository Accreditation Program.
Start the process by completing a Feasibility Application. The NDRI Feasibility Committee will review your application and provide a timely response.
START THE PROCESS
Step 1: Download, complete and submit a Feasibility Application.
Step 2: The NDRI Feasibility Committee will review your application and provide a timely response.
NDRI is a Not-For-Profit (501c3) Corporation.